Clinical Trial Update: Ensuring Access to Optimal Therapy in CF: The ENACT Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial named ENACT in cystic fibrosis is currently recruiting, focusing on ensuring access to optimal therapy for CF patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Arkansas Children's Hospital Research Institute | Conditions: Cystic Fibrosis (CF) | Phase 4 | Status: RECRUITING